Epaned (Enalapril Powder for Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 3, 2016 Category: Drugs & Pharmacology Source Type: news
Sacubitril plus valsartan reduces early readmission risk in HF
The risk of readmission within 30 days of heart failure hospitalisation is reduced by a quarter for patients receiving sacubitril/valsartan compared with those receiving enalapril, an analysis of PARADIGM-HF trial data shows. (Source: MedWire News)
Source: MedWire News - July 13, 2016 Category: Consumer Health News Tags: Heart failure Source Type: news
Sacubitril/Valsartan Cuts Readmissions After Heart Failure Hospitalization (FREE)
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD
Patients taking the heart failure treatment sacubitril/valsartan are less likely than those taking enalapril to be readmitted after an HF hospitalization, according to … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - July 11, 2016 Category: Primary Care Source Type: news
Thousands of patients to benefit from £3-a-day treatment rolled out in hospitals from next month
Sacubitril valsartan cuts death rates by a fifth when compared with enalapril – the current ‘gold standard’ heart failure treatment – and will be rolled out to hospitals in the next month. (Source: the Mail online | Health)
Source: the Mail online | Health - April 27, 2016 Category: Consumer Health News Source Type: news
ATMOSPHERE: Aliskiren Not Superior to Enalapril in HFATMOSPHERE: Aliskiren Not Superior to Enalapril in HF
The negative trial came with a regulatory wrinkle, resulting in three responses being published with the study. The deputy editor admits this was "a bit usual," but so were the circumstances. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 20, 2016 Category: Cardiology Tags: Cardiology News Source Type: news
ATMOSPHERE and the RAS Blockade Ceiling in Heart FailureATMOSPHERE and the RAS Blockade Ceiling in Heart Failure
Dr Pina interviews Prof McMurray about the trial on aliskiren and enalapril in HF and the perils of retrospective subgroup analyses. theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 20, 2016 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news
No benefit from addition of aliskiren to 'gold standard' ACE inhibitor
In one of the largest trials ever conducted in patients who have heart failure with reduced ejection fraction -- a measure of the heart's ability to pump blood -- the investigational drug aliskiren failed to show superiority over full-dose treatment with the existing 'gold standard' therapy, the angiotensin-converting enzyme inhibitor enalapril, researchers reported. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 4, 2016 Category: Science Source Type: news
No benefit from addition of aliskiren to 'gold standard' ACE inhibitor
(American College of Cardiology) In one of the largest trials ever conducted in patients who have heart failure with reduced ejection fraction -- a measure of the heart's ability to pump blood -- the investigational drug aliskiren failed to show superiority over full-dose treatment with the existing 'gold standard' therapy, the angiotensin-converting enzyme inhibitor enalapril, researchers reported at the American College of Cardiology's 65th Annual Scientific Session. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 4, 2016 Category: Global & Universal Source Type: news
Teens and medicines that cause birth defects: Do doctors drop the ball?
My 14-year-old daughter recently started taking isotretinoin, a medication that can help severe acne — and that can cause severe birth defects. I knew that there was a process in place for preventing pregnancy in girls taking it, but I was caught off guard by just how many hoops we had to jump through to get her prescription.
There were two pregnancy tests a month apart at the beginning, continued monthly pregnancy tests as well as monthly online questions about contraception and her understanding of the effects of the medicine, and a special ID card that has to be brought to the pharmacy within a very short window after...
Source: New Harvard Health Information - January 19, 2016 Category: Consumer Health News Authors: Claire McCarthy, MD Tags: Children's Health Drugs and Supplements Family Planning and Pregnancy Parenting Source Type: news
Kalev’s story: Advances in medical management of pediatric heart failure
In recent years, the Boston Children’s Hospital Heart Failure team has made significant strides in slowing the progress of heart failure in children. In some cases, disease progression has been slowed enough for the patient to be taken off of the heart transplant list for being “too well.”
The following is part three of a four-part series featuring Heart Center patients who were once listed for transplant but were removed thanks to successful medical management of his or her heart disease.
Searching for answers
Thirty weeks into her second pregnancy, Katie Rosenthal just felt like something was wrong. She asked her o...
Source: Thrive, Children's Hospital Boston - November 30, 2015 Category: Pediatrics Authors: Erin Horan Tags: Our patients’ stories congenital heart disease Dr. Leslie Smoot Dr. Pedro del Nido Dr. Sitiram Emani Dr. Wayne Tworetsky heart failure heart transplant Heart transplant program Source Type: news
Folic acid, a B vitamin, lowers stroke risk in people with high blood pressure
If you’re among the one in three American adults with high blood pressure, be sure you’re getting plenty of the B vitamin known as folate. Doing so may lower your odds of having a stroke, an often disabling or deadly event linked to high blood pressure, a new study suggests.
Folate occurs naturally in many foods, but especially green leafy vegetables, beans, and citrus fruits. Here in the United States, add to the list most grain products, including wheat flour, cornmeal, pasta, and rice. They are fortified with the synthetic version of folate, known as folic acid.
That’s not the case in many countries ar...
Source: New Harvard Health Information - March 18, 2015 Category: Consumer Health News Authors: Julie Corliss Tags: Drugs and Supplements Hypertension and Stroke high blood pressure Source Type: news
Folate Supplementation in HTN May Lower Risk for First StrokeFolate Supplementation in HTN May Lower Risk for First Stroke
Investigators from China say it's time to rethink the possible CV benefits of folic-acid supplementation: adding it to enalapril reduced risk of first stroke in hypertensive patients without CHD. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 16, 2015 Category: Cardiology Tags: Cardiology News Source Type: news
Folic acid supplementation among adults with hypertension reduces risk of stroke
(The JAMA Network Journals) In a study that included more than 20,000 adults in China with high blood pressure but without a history of stroke or heart attack, the combined use of the hypertension medication enalapril and folic acid, compared with enalapril alone, significantly reduced the risk of first stroke, according to a study appearing in JAMA. The study is being released to coincide with its presentation at the American College of Cardiology Annual Scientific Session. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 15, 2015 Category: Global & Universal Source Type: news
The year in cardiology: heart failure 2014
The year 2014 has become a remarkable year for heart failure. The most important news was related to the results of PARADIGM, where LCZ696, the first-in-class angiotensin-receptor neprilysin inhibitor, proved to be superior to enalapril in reducing mortality and morbidity in patients with heart failure and reduced ejection fraction (HFrEF).
Read more.
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - February 23, 2015 Category: Cardiology Source Type: news
enalapril, Vasotec, Epaned
Title: enalapril, Vasotec, EpanedCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 1/29/2015 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - January 29, 2015 Category: Cardiology Source Type: news
